Is Etofenamatum [INN-Latin] Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use Etofenamatum [INN-Latin]? Is Etofenamatum [INN-Latin] safe for nursing mother and child? Does Etofenamatum [INN-Latin] extracts into breast milk? Does Etofenamatum [INN-Latin] has any long term or short term side effects on infants? Can Etofenamatum [INN-Latin] influence milk supply or can Etofenamatum [INN-Latin] decrease milk supply in lactating mothers?
Etofenamatum [INN-Latin] lactation summary
![Etofenamatum [INN-Latin] usage has low risk in breastfeeding](/images/breastfeeding/low-risk-in-breastfeeding.jpg "Etofenamatum [INN-Latin] breastfeeding")
- DrLact safety Score for Etofenamatum [INN-Latin] is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of Etofenamatum [INN-Latin] may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that Etofenamatum [INN-Latin] may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of Etofenamatum [INN-Latin] low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using Etofenamatum [INN-Latin] We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About Etofenamatum [INN-Latin] usage in lactation
It is a non-steroidal anti-inflammatory which is derived from Flufenamic acid, topically used but it can also be orally or intravenously administered. At latest update relevant data related to breastfeeding were not found. However, we have information on its precursor the Flufenamic acid which is excreted into breast milk in non-significant amount and considered by the American Academy of Pediatrics as usual compatible with breastfeeding. Absorption from skin to the plasma has been reported. A high protein-binding capacity makes excretion into breast milk highly unlikely. However, it would be safer for both the mother and the infant the use of anti-inflammatory products with a proven safety while breastfeeding. Avoid the use on the nipple or on extensive skin areas or long-term treatments to prevent systemic absorption.
Alternate Drugs for Antiinflammatory preparations, non-steroids for topical use. ATC M02
Capsaicin(Low Risk)
Carbenoxolone Sodium(Safe)
Dimethyl Sulfoxide(Low Risk)
Etofenamate(Low Risk)
Flufenamic Acid(Safe)
Trolamine Salicylate(Safe)